{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T01:17:35Z","timestamp":1767921455778,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The human interleukin-17 (IL-17) family comprises IL-17A to IL-17\u00a0F; their receptors are IL-17RA to IL-17RE. Evidence revealed that these cytokines can have a tumor-supportive or anti-tumor impact on human malignancies. The purpose of this study was to assess the expression of <jats:italic>CXCR2<\/jats:italic>, <jats:italic>IL-17RA<\/jats:italic>, and <jats:italic>IL-17RC<\/jats:italic> genes at the mRNA level as well as tissue and serum levels of IL-17A, vascular endothelial growth factor (VEGF), and transforming growth factor \u03b2 (TGF-\u03b2) in patients with bladder cancer (BC) compared to control.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>This study showed that gene expression of <jats:italic>IL-17RA<\/jats:italic>, <jats:italic>IL-17RC<\/jats:italic>, and <jats:italic>CXCR2<\/jats:italic> in the tumoral tissue of BC patients was significantly upregulated compared with normal tissue. The findings disclosed a significant difference in the serum and tissue concentrations of IL-17A, VEGF, and TGF-\u03b2 between the patient and the control groups, as well as tumor and normal tissues.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study reveals notable dysregulation of <jats:italic>CXCR2, IL-17RA<\/jats:italic>, and <jats:italic>IL-17RC<\/jats:italic> genes, alongside changes in IL-17A, VEGF, and TGF-\u03b2 levels in patients with BC than in controls. These findings indicate their possible involvement in BC development and their potential as diagnostic and therapeutic targets.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12865-024-00612-4","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T09:01:42Z","timestamp":1711011702000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association of interleukin-17A and chemokine\/vascular endothelial growth factor-induced angiogenesis in newly diagnosed patients with bladder cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Ali","family":"Moadab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Rafie","family":"Valizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Khorramdelazad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"issue":"1","key":"612_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. Ca Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"Ca Cancer J Clin"},{"key":"612_CR2","doi-asserted-by":"crossref","unstructured":"Shadab R, Nerli R, Bidi SR, Ghagane SC. Risk factors for bladder Cancer: results of a survey of Hospital patients. J Cancer Allied Specialties. 2023;9(1).","DOI":"10.37029\/jcas.v9i1.485"},{"key":"612_CR3","doi-asserted-by":"crossref","unstructured":"Candeias M, Gaipl SS. U. The immune system in cancer prevention, development and therapy. Anti-cancer agents in Medicinal Chemistry (formerly current Medicinal Chemistry-Anti-cancer agents). 2016;16(1):101\u20137.","DOI":"10.2174\/1871520615666150824153523"},{"issue":"7","key":"612_CR4","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.7314\/APJCP.2015.16.7.2725","volume":"16","author":"H Khorramdelazad","year":"2015","unstructured":"Khorramdelazad H, Bagheri V, Hassanshahi G, Karami H, Moogooei M, Zeinali M, et al. S100A12 and RAGE expression in human bladder transitional cell carcinoma: a role for the ligand\/RAGE axis in tumor progression. Asian Pac J Cancer Prev. 2015;16(7):2725\u20139.","journal-title":"Asian Pac J Cancer Prev"},{"key":"612_CR5","doi-asserted-by":"crossref","unstructured":"O\u2019Shea JJ, Gadina M, Siegel RM. Cytokines and cytokine receptors. Clinical Immunology (Fifth Edition): Elsevier; 2019. p. 127\u2009\u2013\u200955. e1.","DOI":"10.1016\/B978-0-7020-6896-6.00009-0"},{"key":"612_CR6","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s12031-011-9672-6","volume":"47","author":"H Azin","year":"2012","unstructured":"Azin H, Vazirinejad R, Ahmadabadi BN, Khorramdelazad H, Zarandi ER, Arababadi MK, et al. The SDF-1 3\u2032 a genetic variation of the chemokine SDF-1\u03b1 (CXCL12) in parallel with its increased circulating levels is associated with susceptibility to MS: a study on Iranian multiple sclerosis patients. J Mol Neurosci. 2012;47:431\u20136.","journal-title":"J Mol Neurosci"},{"issue":"10","key":"612_CR7","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.intimp.2005.05.003","volume":"5","author":"K Rakesh","year":"2005","unstructured":"Rakesh K, Agrawal DK. Cytokines and growth factors involved in apoptosis and proliferation of vascular smooth muscle cells. Int Immunopharmacol. 2005;5(10):1487\u2013506.","journal-title":"Int Immunopharmacol"},{"key":"612_CR8","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s10147-017-1187-x","volume":"22","author":"A Nazari","year":"2017","unstructured":"Nazari A, Khorramdelazad H, Hassanshahi G. Biological\/pathological functions of the CXCL12\/CXCR4\/CXCR7 axes in the pathogenesis of bladder cancer. Int J Clin Oncol. 2017;22:991\u20131000.","journal-title":"Int J Clin Oncol"},{"key":"612_CR9","doi-asserted-by":"crossref","unstructured":"Zamarron BF, Chen WJI. Dual roles of immune cells and their factors in cancer development and progression. 2011;7(5):651.","DOI":"10.7150\/ijbs.7.651"},{"key":"612_CR10","doi-asserted-by":"crossref","unstructured":"Landskron G, De la Fuente M, Thuwajit P, Thuwajit C. Hermoso MAJJoir. Chronic inflammation and cytokines in the tumor microenvironment. 2014;2014.","DOI":"10.1155\/2014\/149185"},{"issue":"4","key":"612_CR11","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1600-0897.2012.01167.x","volume":"68","author":"F Aminzadeh","year":"2012","unstructured":"Aminzadeh F, Ghorashi Z, Nabati S, Ghasemshirazi M, Arababadi MK, Shamsizadeh A, et al. Differential expression of CXC Chemokines CXCL 10 and CXCL 12 in term and pre-term neonates and their mothers. Am J Reprod Immunol. 2012;68(4):338\u201344.","journal-title":"Am J Reprod Immunol"},{"key":"612_CR12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jneuroim.2015.11.021","volume":"290","author":"H Khorramdelazad","year":"2016","unstructured":"Khorramdelazad H, Bagheri V, Hassanshahi G, Zeinali M, Vakilian A. New insights into the role of stromal cell-derived factor 1 (SDF-1\/CXCL12) in the pathophysiology of multiple sclerosis. J Neuroimmunol. 2016;290:70\u20135.","journal-title":"J Neuroimmunol"},{"issue":"12","key":"612_CR13","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1007\/s00262-008-0502-9","volume":"57","author":"T Benatar","year":"2008","unstructured":"Benatar T, Cao MY, Lee Y, Li H, Feng N, Gu X, et al. Virulizin\u00ae induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors. Cancer Immunol Immunother. 2008;57(12):1757\u201369.","journal-title":"Cancer Immunol Immunother"},{"issue":"5","key":"612_CR14","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/cr.2007.35","volume":"17","author":"SH Chang","year":"2007","unstructured":"Chang SH, Dong C. A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses. Cell Res. 2007;17(5):435.","journal-title":"Cell Res"},{"issue":"7","key":"612_CR15","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.4049\/jimmunol.0901017","volume":"183","author":"G Murugaiyan","year":"2009","unstructured":"Murugaiyan G, Saha B. Protumor vs antitumor functions of IL-17. J Immunol. 2009;183(7):4169\u201375.","journal-title":"J Immunol"},{"issue":"2","key":"612_CR16","first-page":"1065","volume":"20","author":"L Liu","year":"2019","unstructured":"Liu L, Sun H, Wu S, Tan H, Sun Y, Liu X, et al. IL\u201317A promotes CXCR2\u2013dependent angiogenesis in a mouse model of liver cancer. Mol Med Rep. 2019;20(2):1065\u201374.","journal-title":"Mol Med Rep"},{"key":"612_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3389\/fonc.2020.00221","volume":"10","author":"Y Haibe","year":"2020","unstructured":"Haibe Y, Kreidieh M, El Hajj H, Khalifeh I, Mukherji D, Temraz S, et al. Resistance mechanisms to anti-angiogenic therapies in cancer. Front Oncol. 2020;10:221.","journal-title":"Front Oncol"},{"issue":"2","key":"612_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.achaem.2014.04.017","volume":"45","author":"A Karczmarczyk","year":"2014","unstructured":"Karczmarczyk A, Karp M, Giannopoulos K. The role of Th17 cells in tumor immunity. Acta Haematol Pol. 2014;45(2):155\u201360.","journal-title":"Acta Haematol Pol"},{"issue":"3","key":"612_CR19","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1111\/jcmm.13442","volume":"22","author":"HJ Yang","year":"2018","unstructured":"Yang HJ, Liu GL, Liu B, Liu T. GP 73 promotes invasion and metastasis of bladder cancer by regulating the epithelial\u2013mesenchymal transition through the TGF-\u03b21\/Smad2 signalling pathway. J Cell Mol Med. 2018;22(3):1650\u201365.","journal-title":"J Cell Mol Med"},{"key":"612_CR20","doi-asserted-by":"crossref","unstructured":"Lepara Z, Lepara O, Fajki\u0107 A, Rebi\u0107 D, Ali\u0107 J, Spahovi\u0107 H. Serum malondialdehyde (MDA) level as a potential biomarker of cancer progression for patients with bladder cancer. Rom J Intern Med. 2020;1(ahead-of-print).","DOI":"10.2478\/rjim-2020-0008"},{"issue":"7","key":"612_CR21","first-page":"2620","volume":"101","author":"M Numasaki","year":"2003","unstructured":"Numasaki M, Fukushi J-i, Ono M, Narula SK, Zavodny PJ, Kudo T, et al. Interleukin-17 promotes angiogenesis and tumor growth. Blood J Am Soc Hematol. 2003;101(7):2620\u20137.","journal-title":"Blood J Am Soc Hematol"},{"key":"612_CR22","doi-asserted-by":"publisher","first-page":"5493","DOI":"10.1007\/s13277-015-4372-4","volume":"37","author":"X Wu","year":"2016","unstructured":"Wu X, Yang T, Liu X, Guo JN, Xie T, Ding Y, et al. IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer. Tumor Biology. 2016;37:5493\u2013501.","journal-title":"Tumor Biology"},{"issue":"1","key":"612_CR23","doi-asserted-by":"publisher","first-page":"16053","DOI":"10.1038\/srep16053","volume":"5","author":"B Pan","year":"2015","unstructured":"Pan B, Shen J, Cao J, Zhou Y, Shang L, Jin S, et al. Interleukin-17 promotes angiogenesis by stimulating VEGF production of cancer cells via the STAT3\/GIV signaling pathway in non-small-cell lung cancer. Sci Rep. 2015;5(1):16053.","journal-title":"Sci Rep"},{"issue":"2","key":"612_CR24","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.bbrc.2011.03.021","volume":"407","author":"J Liu","year":"2011","unstructured":"Liu J, Duan Y, Cheng X, Chen X, Xie W, Long H, et al. IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma. Biochem Biophys Res Commun. 2011;407(2):348\u201354.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"612_CR25","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1002\/eji.200526021","volume":"35","author":"K Mihara","year":"2005","unstructured":"Mihara K, Smit MJ, Krajnc-Franken M, Gossen J, Rooseboom M, Dokter W. Human CXCR2 (hCXCR2) takes over functionalities of its murine homolog in hCXCR2 knockin mice. Eur J Immunol. 2005;35(9):2573\u201382.","journal-title":"Eur J Immunol"},{"issue":"9","key":"612_CR26","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.4049\/jimmunol.165.9.5269","volume":"165","author":"CL Addison","year":"2000","unstructured":"Addison CL, Daniel TO, Burdick MD, Liu H, Ehlert JE, Xue YY, et al. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR\u2009+\u2009CXC chemokine-induced angiogenic activity. J Immunol. 2000;165(9):5269\u201377.","journal-title":"J Immunol"},{"issue":"1","key":"612_CR27","first-page":"93","volume":"152","author":"Y Kitadai","year":"1998","unstructured":"Kitadai Y, Haruma K, Sumii K, Yamamoto S, Ue T, Yokozaki H, et al. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Pathol. 1998;152(1):93.","journal-title":"Am J Pathol"},{"issue":"8","key":"612_CR28","doi-asserted-by":"publisher","first-page":"5351","DOI":"10.4049\/jimmunol.175.8.5351","volume":"175","author":"J Mestas","year":"2005","unstructured":"Mestas J, Burdick MD, Reckamp K, Pantuck A, Figlin RA, Strieter RM. The role of CXCR2\/CXCR2 ligand biological axis in renal cell carcinoma. J Immunol. 2005;175(8):5351\u20137.","journal-title":"J Immunol"},{"key":"612_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-015-0730-7","volume":"13","author":"B Zhu","year":"2015","unstructured":"Zhu B, Lin N, Zhang M, Zhu Y, Cheng H, Chen S, et al. Activated hepatic stellate cells promote angiogenesis via interleukin-8 in hepatocellular carcinoma. J Translational Med. 2015;13:1\u201310.","journal-title":"J Translational Med"},{"issue":"9","key":"612_CR30","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.4049\/jimmunol.175.9.6177","volume":"175","author":"M Numasaki","year":"2005","unstructured":"Numasaki M, Watanabe M, Suzuki T, Takahashi H, Nakamura A, McAllister F, et al. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol. 2005;175(9):6177\u201389.","journal-title":"J Immunol"},{"issue":"1","key":"612_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12865-016-0174-8","volume":"17","author":"Y Liu","year":"2016","unstructured":"Liu Y, Yang W, Zhao L, Liang Z, Shen W, Hou Q, et al. Immune analysis of expression of IL-17 relative ligands and their receptors in bladder cancer: comparison with polyp and cystitis. BMC Immunol. 2016;17(1):1\u201310.","journal-title":"BMC Immunol"},{"key":"612_CR32","doi-asserted-by":"crossref","unstructured":"Nalbant AJJI, Research C. IL-17, IL-21, and IL-22 cytokines of T Helper 17 cells in Cancer. 2019;39(1):56\u201360.","DOI":"10.1089\/jir.2018.0057"},{"issue":"6","key":"612_CR33","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s10147-017-1187-x","volume":"22","author":"A Nazari","year":"2017","unstructured":"Nazari A, Khorramdelazad H, Hassanshahi G. Biological\/pathological functions of the CXCL12\/CXCR4\/CXCR7 axes in the pathogenesis of bladder cancer. Int J Clin Oncol. 2017;22(6):991\u20131000.","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"612_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12950-015-0057-4","volume":"12","author":"B Debelec-Butuner","year":"2015","unstructured":"Debelec-Butuner B, Ertunc N, Korkmaz KS. Inflammation contributes to NKX3. 1 loss and augments DNA damage but does not alter the DNA damage response via increased SIRT1 expression. J Inflamm. 2015;12(1):12.","journal-title":"J Inflamm"},{"key":"612_CR35","doi-asserted-by":"crossref","unstructured":"Young MRI. Th17 cells in protection from tumor or promotion of tumor progression. J Clin Cell Immunol. 2016;7(3).","DOI":"10.4172\/2155-9899.1000431"},{"key":"612_CR36","doi-asserted-by":"crossref","unstructured":"Razi S, Noveiry BB, Keshavarz-Fathi M, Rezaei NJC. IL-17 and colorectal cancer: from carcinogenesis to treatment. 2019;116:7\u201312.","DOI":"10.1016\/j.cyto.2018.12.021"},{"issue":"1","key":"612_CR37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12865-016-0174-8","volume":"17","author":"Y Liu","year":"2016","unstructured":"Liu Y, Yang W, Zhao L, Liang Z, Shen W, Hou Q, et al. Immune analysis of expression of IL-17 relative ligands and their receptors in bladder cancer: comparison with polyp and cystitis. BMC Immunol. 2016;17(1):36.","journal-title":"BMC Immunol"},{"issue":"9","key":"612_CR38","doi-asserted-by":"publisher","first-page":"6536","DOI":"10.4049\/jimmunol.181.9.6536","volume":"181","author":"JW Lee","year":"2008","unstructured":"Lee JW, Wang P, Kattah MG, Youssef S, Steinman L, DeFea K, et al. Differential regulation of chemokines by IL-17 in colonic epithelial cells. J Immunol. 2008;181(9):6536\u201345.","journal-title":"J Immunol"},{"issue":"2","key":"612_CR39","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jcmgh.2022.10.013","volume":"15","author":"R Yan","year":"2023","unstructured":"Yan R, Li J, Xiao Z, Fan X, Liu H, Xu Y, et al. DCLK1 suppresses tumor-specific cytotoxic T lymphocyte function through recruitment of MDSCs via the CXCL1-CXCR2 Axis. Cell Mol Gastroenterol Hepatol. 2023;15(2):463\u201385.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"612_CR40","doi-asserted-by":"publisher","first-page":"215598","DOI":"10.1016\/j.canlet.2022.215598","volume":"532","author":"X Zhou","year":"2022","unstructured":"Zhou X, Fang D, Liu H, Ou X, Zhang C, Zhao Z, et al. PMN-MDSCs accumulation induced by CXCL1 promotes CD8\u2009+\u2009T cells exhaustion in gastric cancer. Cancer Lett. 2022;532:215598.","journal-title":"Cancer Lett"},{"issue":"4","key":"612_CR41","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.joca.2005.10.004","volume":"14","author":"M Honorati","year":"2006","unstructured":"Honorati M, Neri S, Cattini L, Facchini A. Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts. Osteoarthr Cartil. 2006;14(4):345\u201352.","journal-title":"Osteoarthr Cartil"},{"key":"612_CR42","doi-asserted-by":"crossref","unstructured":"Khalid F, Takagi K, Sato A, Yamaguchi M, Guestini F, Miki Y et al. Interleukin (IL)-17A in triple-negative breast cancer: a potent prognostic factor associated with intratumoral neutrophil infiltration. Breast Cancer. 2023:1\u201310.","DOI":"10.1007\/s12282-023-01467-0"},{"issue":"2","key":"612_CR43","first-page":"103","volume":"18","author":"M Numasaki","year":"2021","unstructured":"Numasaki M, Ito K, VEGF-A. HGF and bFGF are involved in IL-17A-mediated migration and capillary-like vessel formation of vascular endothelial cells. Iran J Immunol. 2021;18(2):103\u201310.","journal-title":"Iran J Immunol"},{"key":"612_CR44","doi-asserted-by":"publisher","first-page":"s740","DOI":"10.2741\/1093","volume":"8","author":"X Huang","year":"2003","unstructured":"Huang X, Lee C. Regulation of stromal proliferation, growth arrest, differentiation and apoptosis in benign prostatic hyperplasia by TGF-beta. Front Biosci. 2003;8:s740\u20139.","journal-title":"Front Biosci"},{"issue":"3","key":"612_CR45","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10456-012-9278-9","volume":"15","author":"S Fang","year":"2012","unstructured":"Fang S, Pentinmikko N, Ilmonen M, Salven P. Dual action of TGF-\u03b2 induces vascular growth in vivo through recruitment of angiogenic VEGF-producing hematopoietic effector cells. Angiogenesis. 2012;15(3):511\u20139.","journal-title":"Angiogenesis"},{"key":"612_CR46","doi-asserted-by":"crossref","unstructured":"Liu Y, Xiao Z, Yang J, Lin J, Shen W, An L et al. Increase expression of IL-17A, IL6, STAT3, TGF-\u03b2 and VEGF in bladder Cancer: potential biomarkers? 2020.","DOI":"10.21203\/rs.3.rs-19288\/v1"},{"key":"612_CR47","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fimmu.2019.00008","volume":"10","author":"K Vermaelen","year":"2019","unstructured":"Vermaelen K. Vaccine strategies to improve anti-cancer cellular immune responses. Front Immunol. 2019;10:8.","journal-title":"Front Immunol"},{"key":"612_CR48","doi-asserted-by":"publisher","first-page":"6995","DOI":"10.2147\/CMAR.S208984","volume":"11","author":"J Zou","year":"2019","unstructured":"Zou J, Huang R, Li H, Wang B, Chen Y, Chen S, et al. Secreted TGF-beta-induced protein promotes aggressive progression in bladder cancer cells. Cancer Manage Res. 2019;11:6995.","journal-title":"Cancer Manage Res"},{"issue":"3","key":"612_CR49","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.4049\/jimmunol.0902813","volume":"184","author":"X Su","year":"2010","unstructured":"Su X, Ye J, Hsueh EC, Zhang Y, Hoft DF, Peng G. Tumor microenvironments direct the recruitment and expansion of human Th17 cells. J Immunol. 2010;184(3):1630\u201341.","journal-title":"J Immunol"},{"issue":"10","key":"612_CR50","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.humimm.2013.06.032","volume":"74","author":"S Chugh","year":"2013","unstructured":"Chugh S, Anand V, Swaroop L, Sharma M, Seth A, Sharma A. Involvement of Th17 cells in patients of urothelial carcinoma of bladder. Hum Immunol. 2013;74(10):1258\u201362.","journal-title":"Hum Immunol"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-024-00612-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-024-00612-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-024-00612-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T09:04:45Z","timestamp":1711011885000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-024-00612-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["612"],"URL":"https:\/\/doi.org\/10.1186\/s12865-024-00612-4","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,21]]},"assertion":[{"value":"27 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Rafsanjan University of Medical Sciences ethics committee approved the study protocol. The research was performed according to the ethical standards of the Rafsanjan University of Medical Sciences. Informed consent was received from all participants. All methods were carried out in accordance with the tenants of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent to publish was obtained from the study participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}